Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. more
Time Frame | GLYC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.12% | -0.33% | -1.49% |
1-Month Return | -24.62% | -4.57% | -0.37% |
3-Month Return | 31.61% | -9.96% | 3.89% |
6-Month Return | -18.79% | -5.67% | 9.34% |
1-Year Return | -91.41% | 2.53% | 25.19% |
3-Year Return | -85.66% | -1.43% | 24.7% |
5-Year Return | -96.14% | 34.73% | 85.39% |
10-Year Return | -97.23% | 102.14% | 187.19% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 9.00M | 10.16M | 1.16M | 74.92K | 10.00K | [{"date":"2019-12-31","value":88.56,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":11.41,"profit":true},{"date":"2022-12-31","value":0.74,"profit":true},{"date":"2023-12-31","value":0.1,"profit":true}] |
Cost of Revenue | 899.30K | - | 1.01M | 1.03M | 153.30K | [{"date":"2019-12-31","value":87.13,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":98.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.85,"profit":true}] |
Gross Profit | (899.30K) | 10.16M | 1.16M | 74.92K | 10.00K | [{"date":"2019-12-31","value":-8.85,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":11.41,"profit":true},{"date":"2022-12-31","value":0.74,"profit":true},{"date":"2023-12-31","value":0.1,"profit":true}] |
Gross Margin | (9.99%) | 100.00% | 100.00% | 100.00% | 100.00% | [{"date":"2019-12-31","value":-9.99,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 61.39M | 61.67M | 64.61M | 47.48M | 39.29M | [{"date":"2019-12-31","value":95.02,"profit":true},{"date":"2020-12-31","value":95.46,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.49,"profit":true},{"date":"2023-12-31","value":60.81,"profit":true}] |
Operating Income | (61.39M) | (51.51M) | (63.45M) | (47.40M) | (39.28M) | [{"date":"2019-12-31","value":-6138900000,"profit":false},{"date":"2020-12-31","value":-5150900000,"profit":false},{"date":"2021-12-31","value":-6344700000,"profit":false},{"date":"2022-12-31","value":-4740300000,"profit":false},{"date":"2023-12-31","value":-3927529300,"profit":false}] |
Total Non-Operating Income/Expense | 6.99M | 964.00K | 39.77K | 1.43M | 4.62M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":13.78,"profit":true},{"date":"2021-12-31","value":0.57,"profit":true},{"date":"2022-12-31","value":20.44,"profit":true},{"date":"2023-12-31","value":66.02,"profit":true}] |
Pre-Tax Income | (57.89M) | (51.03M) | (63.43M) | (46.69M) | (36.90M) | [{"date":"2019-12-31","value":-5789200000,"profit":false},{"date":"2020-12-31","value":-5102700000,"profit":false},{"date":"2021-12-31","value":-6342700000,"profit":false},{"date":"2022-12-31","value":-4668800000,"profit":false},{"date":"2023-12-31","value":-3689942000,"profit":false}] |
Income Taxes | (3.78M) | (752.75K) | (284.60K) | 46.64M | (637.00) | [{"date":"2019-12-31","value":-8.1,"profit":false},{"date":"2020-12-31","value":-1.61,"profit":false},{"date":"2021-12-31","value":-0.61,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (54.12M) | (50.27M) | (63.14M) | (93.33M) | (36.90M) | [{"date":"2019-12-31","value":-5411576600,"profit":false},{"date":"2020-12-31","value":-5027424600,"profit":false},{"date":"2021-12-31","value":-6314240000,"profit":false},{"date":"2022-12-31","value":-9332859668,"profit":false},{"date":"2023-12-31","value":-3689878300,"profit":false}] |
Income From Continuous Operations | (57.89M) | (51.03M) | (63.43M) | (46.69M) | (38.06M) | [{"date":"2019-12-31","value":-5789191100,"profit":false},{"date":"2020-12-31","value":-5102690300,"profit":false},{"date":"2021-12-31","value":-6342743700,"profit":false},{"date":"2022-12-31","value":-4668835900,"profit":false},{"date":"2023-12-31","value":-3806408100,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (54.12M) | (50.27M) | (63.14M) | (93.33M) | (36.90M) | [{"date":"2019-12-31","value":-5411576600,"profit":false},{"date":"2020-12-31","value":-5027424600,"profit":false},{"date":"2021-12-31","value":-6314240000,"profit":false},{"date":"2022-12-31","value":-9332859668,"profit":false},{"date":"2023-12-31","value":-3689942000,"profit":false}] |
EPS (Diluted) | (1.35) | (1.11) | (1.23) | (0.88) | (0.58) | [{"date":"2019-12-31","value":-135,"profit":false},{"date":"2020-12-31","value":-111,"profit":false},{"date":"2021-12-31","value":-123,"profit":false},{"date":"2022-12-31","value":-88,"profit":false},{"date":"2023-12-31","value":-58,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
GLYC | |
---|---|
Cash Ratio | 3.33 |
Current Ratio | 3.62 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
GLYC | |
---|---|
ROA (LTM) | -59.25% |
ROE (LTM) | -104.49% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
GLYC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.28 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.72 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
GLYC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1396.08 |
P/B | 1.32 |
Price/FCF | NM |
EV/R | 94.04 |
EV/Ebitda | NM |
PEG | NM |
GlycoMimetics Inc (GLYC) share price today is $0.242
Yes, Indians can buy shares of GlycoMimetics Inc (GLYC) on Vested. To buy GlycoMimetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GLYC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of GlycoMimetics Inc (GLYC) via the Vested app. You can start investing in GlycoMimetics Inc (GLYC) with a minimum investment of $1.
You can invest in shares of GlycoMimetics Inc (GLYC) via Vested in three simple steps:
The 52-week high price of GlycoMimetics Inc (GLYC) is $3.53. The 52-week low price of GlycoMimetics Inc (GLYC) is $0.14.
The price-to-earnings (P/E) ratio of GlycoMimetics Inc (GLYC) is
The price-to-book (P/B) ratio of GlycoMimetics Inc (GLYC) is 1.32
The dividend yield of GlycoMimetics Inc (GLYC) is 0.00%
The market capitalization of GlycoMimetics Inc (GLYC) is $13.96M
The stock symbol (or ticker) of GlycoMimetics Inc is GLYC